The new facility will be adjacent to Thermo Fisher’s newly expanded biologics manufacturing facility.
Thermo Fisher Scientific announced on Sept. 9, 2020 that it is opening a new Bioprocessing Collaboration Center in St. Louis, MO.
According to a company press release, the new facility will be adjacent to Thermo Fisher’s newly expanded biologics manufacturing facility.
“Our St. Louis site is among the world's largest producers of biologics using single-use technology and the ideal location for this unique collaboration," said Michael Shafer, senior vice-president and president, pharma services, Thermo Fisher Scientific, in the press release. "These complementary businesses will work together to develop innovative bioprocessing technologies, products and services. This will enhance bioprocess workflows and enable our customers to take their products to market faster and with greater efficiency."
Source: Thermo Fisher
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.